330 related articles for article (PubMed ID: 9797884)
1. ACE inhibitors in acute myocardial infarction.
Murdoch DR; McMurray JJ
Hosp Med; 1998 Feb; 59(2):111-5. PubMed ID: 9797884
[TBL] [Abstract][Full Text] [Related]
2. Drug prescriptions after acute myocardial infarction: dosage, compliance, and persistence.
Simpson E; Beck C; Richard H; Eisenberg MJ; Pilote L
Am Heart J; 2003 Mar; 145(3):438-44. PubMed ID: 12660666
[TBL] [Abstract][Full Text] [Related]
3. Dual renin angiotensin system blockade in patients with acute myocardial infarction and preserved left ventricular systolic function.
Suşan M; Petrescu L; Riviş AI; Suşan RM; Burghină D; Dan R; Cozma D; Drăgulescu SI
Rom J Intern Med; 2005; 43(3-4):187-98. PubMed ID: 16812979
[TBL] [Abstract][Full Text] [Related]
4. [Effect of combined beta-blocker and angiotensin-converting enzyme inhibitor treatment on 1-year survival after acute myocardial infarction: findings of the PRIAMHO-II registry].
Arós F; Loma-Osorio A; Vila J; López-Bescós L; Cuñat J; Rodríguez E; San José JM; Heras M; Marrugat J;
Rev Esp Cardiol; 2006 Apr; 59(4):313-20. PubMed ID: 16709383
[TBL] [Abstract][Full Text] [Related]
5. Which inhibitor of the renin-angiotensin system should be used in chronic heart failure and acute myocardial infarction?
McMurray JJ; Pfeffer MA; Swedberg K; Dzau VJ
Circulation; 2004 Nov; 110(20):3281-8. PubMed ID: 15545527
[No Abstract] [Full Text] [Related]
6. [Multi-drug management after myocardial infarct].
Kritz H; Sinzinger H
Wien Klin Wochenschr; 1997; 109 Suppl 2():17-24. PubMed ID: 9340918
[TBL] [Abstract][Full Text] [Related]
7. Treatments that improve outcome in the patient with heart failure, left ventricular systolic dysfunction, or both after acute myocardial infarction.
Weir R; McMurray JJ
Heart; 2005 May; 91 Suppl 2(Suppl 2):ii17-20; discussion ii31, ii43-8. PubMed ID: 15831602
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
[TBL] [Abstract][Full Text] [Related]
9. [Magnesium sulfate in acute myocardial infarction].
Balli E; Giomi A; Del Citerna F
G Ital Cardiol; 1995 Nov; 25(11):1425-32. PubMed ID: 8682239
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin-converting enzyme inhibition in myocardial infarction--Part 2: Clinical issues and controversies.
Huckell VF; Bernstein V; Crowell R; Dagenais GR; Higginson LA; Isserow S; Laramée P; Liu P; McCans JL; Orchard RC; Prewitt R; Quinn BP; Samson M; Turazza F; Warnica JW; Wielgosz A
Can J Cardiol; 1997 Feb; 13(2):173-82. PubMed ID: 9070169
[TBL] [Abstract][Full Text] [Related]
11. Prognostic impact of acute beta-blocker therapy on top of aspirin and angiotensin-converting enzyme inhibitor therapy in consecutive patients with ST-elevation acute myocardial infarction.
Wienbergen H; Zeymer U; Gitt AK; Juenger C; Schiele R; Heer T; Towae F; Senges J;
Am J Cardiol; 2007 May; 99(9):1208-11. PubMed ID: 17478143
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of beta blockers in high-risk patients after myocardial infarction in conjunction with captopril and/or valsartan (from the VALsartan In Acute Myocardial Infarction [VALIANT] trial).
Califf RM; Lokhnygina Y; Velazquez EJ; McMurray JJ; Leimberger JD; Lewis EF; Diaz R; Murin J; Pfeffer MA
Am J Cardiol; 2009 Jul; 104(2):151-7. PubMed ID: 19576338
[TBL] [Abstract][Full Text] [Related]
13. Left ventricular systolic dysfunction and atrial fibrillation in older people in the community--a need for screening?
Ho SF; O'Mahony MS; Steward JA; Burr ML; Buchalter M
Age Ageing; 2004 Sep; 33(5):488-92. PubMed ID: 15271642
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin-converting enzyme inhibitor and/or angiotensin receptor antagonist for the postmyocardial infarction patient.
Scott RL
Cardiol Clin; 2008 Feb; 26(1):73-7, vii. PubMed ID: 18312907
[TBL] [Abstract][Full Text] [Related]
15. A pragmatic approach to the use of angiotensin-converting enzyme inhibitors in acute myocardial infarction.
Vantrimpont P; Rouleau JL
Can J Cardiol; 1996 Oct; 12(10):924-9. PubMed ID: 9191482
[TBL] [Abstract][Full Text] [Related]
16. Medical management after myocardial infarction: an evidence-based perspective.
Sharpe N
Br J Clin Pract Suppl; 1996 Jul; 84():25-30. PubMed ID: 8994999
[TBL] [Abstract][Full Text] [Related]
17. Utilization of evidence-based therapy for the secondary prevention of acute coronary syndromes in Australian practice.
Vermeer NS; Bajorek BV
J Clin Pharm Ther; 2008 Dec; 33(6):591-601. PubMed ID: 19138236
[TBL] [Abstract][Full Text] [Related]
18. AT1 receptor blockade for the prevention of cardiovascular events after myocardial infarction.
Azadpour M; Lamas GA
Expert Rev Cardiovasc Ther; 2004 Nov; 2(6):891-902. PubMed ID: 15500434
[TBL] [Abstract][Full Text] [Related]
19. [Relationship between mortality due to acute myocardial infarction and adherence to clinical guidelines].
Coma-Canella I
Rev Esp Cardiol; 2006 Mar; 59(3):189-92. PubMed ID: 16712740
[No Abstract] [Full Text] [Related]
20. Mechanistic and clinical rationales for using beta-blockers in heart failure.
Bristow MR
J Card Fail; 2000 Jun; 6(2 Suppl 1):8-14. PubMed ID: 10908093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
